ARTICLE | Company News
Emergent BioSolutions, Valneva deal
March 17, 2014 7:00 AM UTC
Valneva transferred a license to develop vaccines for tuberculosis (TB) using its EB66 cell line to Emergent from the Oxford-Emergent Tuberculosis Consortium (OETC) Ltd. Valneva said financial terms o...